Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carrot Fertility provides a global digital platform offering personalized fertility care benefits to employees of client companies. The company reports industry-leading outcomes such as a single embryo transfer rate validated by Milliman and an IVF live birth rate of 55.4%, about 24% higher than the U.S. national average. Their approach reduces C-section rates by up to 31% through expert guidance. They serve millions of members in over 170 countries with more than 11,000 eligible providers. Services include education, egg/sperm freezing, IVF navigation/support, gestational surrogacy/adoption assistance, menopause/low testosterone management. The company does not develop drugs or therapeutics but delivers non-pharmacological digital health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carrot Fertility.